Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suramin for the Treatment of Autism Trial (STAT): A Randomized, Double Blind, Crossover Trial of KZ101 in a Male Pediatric Population With Autism Spectrum Disorder

NCT06866275 is registered in ClinicalTrials.gov with Children's Hospital of Orange County as lead sponsor.

NCT NCT06866275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06866275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suramin for the Treatment of Autism Trial (STAT): A Randomized, Double Blind, Crossover Trial of KZ101 in a Male Pediatric Population With Autism Spectrum Disorder
Lead sponsor
Children's Hospital of Orange County
Phase
Phase 2
Overall status
Recruiting
Start date
April 9, 2025
Completion date
April 30, 2028
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder (asd)